Fielmann Aktie 280923 / DE0005772206
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Orderbuch | Analysen | |||||
| Historisch | ||||||
|
04.11.2025 08:00:03
|
Fielmann Group supports medical study by University Medical Center Hamburg-Eppendorf (UKE) on innovative eyecare
|
Fielmann Group supports medical study by University Medical Center Hamburg-Eppendorf (UKE) on innovative eyecare
Together with Ocumeda, a leading tele-ophthalmological platform in Europe, Fielmann Group introduced the Eye Health Checkup, an innovative medical offering that makes eye health affordable and accessible for everyone. The service has been rolled out since 2024 and is currently being offered in all major Fielmann stores in Austria, Germany and Switzerland. 300,000 customers have already used the service and in 20% of the cases, conspicuous findings led to a recommendation for further checkups and treatments at local ophthalmologists and clinics. This medical service is now being scientifically examined by the University Medical Center Hamburg-Eppendorf (UKE), supported by Fielmann with €600,000. The scientific study is led by the Director of the hospital’s Ophthalmology Department, Prof. Dr. Martin Spitzer. Its goal is to scientifically evaluate the tele-ophthalmological offering, comparing its results to those of a medical eye exam carried out in person by an ophthalmologist at the university clinic. About the Eye Health Service at Fielmann About the medical study – free ophthalmologist consultations for Fielmann customers „Having your eye health checked regularly is important. More than 300,000 customers have already chosen the most convenient way – our medical Eye Health Checkup. By asking one of the most renowned medical research institutions in Europe to scientifically evaluate this innovative service, we underscore Fielmann’s commitment to delivering quality medical services in close collaboration with our partners in ophthalmology. This study marks another important milestone in our Vision 2035 growth strategy, which aims to make primary eyecare accessible and affordable. This way we pursue our purpose – to help everyone hear and see the beauty in the world”, says Marc Fielmann, CEO of the Fielmann Group. Why primary eyecare is important The following Fielmann stores are offering the Eye Health Checkup and are participating in the scientific study:
Hamburg, Germany ? November 4, 2025 Fielmann Group AG The Management Board ABOUT FIELMANN GROUP AG ABOUT OCUMEDA AG ABOUT UKE CONTACT
End of Media Release Issuer: Fielmann Group AG Key word(s): Special Topics
04.11.2025 CET/CEST Dissemination of a Press Release, transmitted by EQS News - a service of EQS Group. |
| Language: | English |
| Company: | Fielmann Group AG |
| Fuhlsbuettler Strasse 399 | |
| 22309 Hamburg | |
| Germany | |
| Phone: | +49 40 270 76-0 |
| Fax: | +49 40 270 76-390 |
| Internet: | www.fielmann-group.com |
| ISIN: | DE0005772206 |
| WKN: | 577220 |
| Indices: | MDAX |
| Listed: | Regulated Market in Berlin, Dusseldorf, Frankfurt (Prime Standard), Hamburg, Hanover, Munich, Stuttgart; Regulated Unofficial Market in Tradegate Exchange |
| EQS News ID: | 2222812 |
| End of News | EQS Media |
|
|
2222812 04.11.2025 CET/CEST
Nachrichten zu Fielmann AG
|
02.12.25 |
MDAX-Handel aktuell: MDAX sackt ab (finanzen.ch) | |
|
02.12.25 |
MDAX-Wert Fielmann-Aktie: So viel Verlust wäre bei einem Investment in Fielmann von vor 5 Jahren angefallen (finanzen.ch) | |
|
25.11.25 |
MDAX-Titel Fielmann-Aktie: So viel Gewinn hätte eine Investition in Fielmann von vor 3 Jahren abgeworfen (finanzen.ch) | |
|
18.11.25 |
MDAX-Wert Fielmann-Aktie: So viel Gewinn hätte ein Investment in Fielmann von vor einem Jahr eingebracht (finanzen.ch) | |
|
11.11.25 |
MDAX-Wert Fielmann-Aktie: So viel hätten Anleger mit einem Investment in Fielmann von vor 10 Jahren verloren (finanzen.ch) | |
|
07.11.25 |
Freitagshandel in Frankfurt: MDAX zum Start des Freitagshandels mit Gewinnen (finanzen.ch) | |
|
06.11.25 |
Fielmann-Aktie steigt: Umsatzsprung - "auf Kurs" (AWP) | |
|
06.11.25 |
Fielmann-Geschäft wächst im Sommer schwächer - Aktie gibt nach (AWP) |
Analysen zu Fielmann AG
| 22.09.25 | Fielmann Halten | DZ BANK | |
| 18.09.25 | Fielmann Hold | Warburg Research | |
| 28.08.25 | Fielmann Hold | Warburg Research | |
| 18.07.25 | Fielmann Halten | DZ BANK | |
| 11.07.25 | Fielmann Add | Baader Bank |
3 neue Aktien 📈 BX Musterportfolio: Eli Lilly and Co, Alphabet & Woodward mit François Bloch
Im BX Morningcall werden folgende Aktien analysiert und erklärt – heute mit dem monatlichen Rebalancing:
NEU✅ Eli Lilly and Co.
NEU✅ Alphabet A
NEU✅ Woodward Inc
inklusive Rebalancing:
❌ Palo Alto Networks
❌ Microsoft
❌ Interactive Brokers
👉🏽 https://bxplus.ch/bx-musterportfolio/
Inside Trading & Investment
Mini-Futures auf SMI
Inside Fonds
Meistgelesene Nachrichten
Top-Rankings
Börse aktuell - Live Ticker
Nach US-Zinsentscheid: US-Börsen schliessen mit Gewinnen -- SMI zum Handelsende knapp im Minus -- DAX schliesst etwas schwächer -- Asiens Börsen letztlich uneinsDer heimische Aktienmarkt tendierte am Mittwoch seitwärts. Der deutsche Leitindex gab leicht nach. US-Anleger zeigten sich in Kauflaune. In Fernost wiesen die wichtigsten Aktienmärkte zur Wochenmitte unterschiedliche Vorzeichen aus.


